This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Antibodies as Drugs
joint with Cancer Immunology and Immunotherapy
Organizer(s): Paul Carter and Andreas G. Plückthun
Date: January 27 - February 01, 2013
Location: Fairmont Hotel Vancouver, Vancouver, BC, Canada
Sponsored by AbbVie Inc., Astellas Pharma Inc. and Genentech, Inc. Supported by an educational donation provided by Amgen.
Summary of Meeting:
Antibodies have come of age as therapeutics since the late 1990s with 26 antibody therapeutics marketed in the USA and approximately 300 additional antibodies in clinical development. Many of these antibody drugs are targeted to malignant cells and are used for the treatment of a variety of cancers. Participants at this meeting will consider new therapeutic opportunities for antibodies and engineered targeting molecules across a broad range of clinical settings including oncology, autoimmunity and chronic inflammation, infectious diseases and neurology. Progress in molecular engineering to increase their clinical potential will be discussed including antibody-drug conjugates, bispecific and multispecific targeting molecules, effector function enhancement and half-life extension. New frontiers will be explored including engineering antibodies to cross the blood-brain barrier and tackling fundamental questions in antibody targeting, mechanisms of action and resistance, and immunogenicity of engineered proteins. This symposium will bring together experts from academia and industry, from molecular engineering to biomedical applications, at the forefront of advancing antibodies as drugs and will be of broad interest to scientists working in this area. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Cancer Immunology and Immunotherapy, which will share two plenary sessions with this meeting.
Scholarship Deadline: September 25 2012
Discounted Abstract Deadline: September 25 2012
Abstract Deadline: October 25 2012
Discounted Registration Deadline: November 27 2012
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
AbbVie Inc.Educational donation provided by AmgenAstellas Pharma Inc.Genentech, Inc.
We gratefully acknowledge additional support for this conference from:
BioLegendImmunoGen, Inc.Seattle Genetics, Inc.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Genentech, Inc.

Micromet, Inc.


MedImmune
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found